Kemp Watson

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. doi request reprint Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
    T van der Kwast
    Department of Pathology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Canada
    Virchows Arch 463:367-77. 2013
  2. doi request reprint Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy
    T van der Kwast
    Dept of Pathology, University Health Network, Toronto, Canada
    Eur J Cancer 48:1318-25. 2012
  3. doi request reprint International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume
    Theo H van der Kwast
    Department of Pathology, University Health Network and University of Toronto, Toronto, ON, Canada
    Mod Pathol 24:16-25. 2011
  4. doi request reprint Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies
    Theodorus H van der Kwast
    Department of Pathology, 11th Floor, University Health Network, 200 Elizabeth Street, Toronto M5G 2C4, Canada
    Am J Surg Pathol 34:169-77. 2010
  5. doi request reprint Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling
    Theodorus H van der Kwast
    Department of Pathology, University Health Network and University of Toronto, Canada
    Curr Opin Urol 19:516-21. 2009
  6. ncbi request reprint Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology
    Theodorus H van der Kwast
    Department of Pathology and Laboratory Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Ontario, Canada
    Anal Quant Cytol Histol 30:309-15. 2008
  7. ncbi request reprint Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911
    Theodorus H van der Kwast
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University Health Network, Toronto, Canada
    J Clin Oncol 25:4178-86. 2007
  8. pmc Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm?
    Th Van der Kwast
    Department of Pathology, University Health Network, Toronto, Ontario, Canada
    J Clin Pathol 60:585-6. 2007
  9. ncbi request reprint Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911)
    Theodorus H van der Kwast
    Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada, and Department of Urology, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium
    Virchows Arch 449:428-34. 2006
  10. doi request reprint Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens
    Andrew J Evans
    Department of Pathology and Laboratory Medicine, University Health Network, Toronto, Ontario, Canada
    Am J Surg Pathol 32:1503-12. 2008

Detail Information

Publications10

  1. doi request reprint Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
    T van der Kwast
    Department of Pathology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Canada
    Virchows Arch 463:367-77. 2013
    ....
  2. doi request reprint Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy
    T van der Kwast
    Dept of Pathology, University Health Network, Toronto, Canada
    Eur J Cancer 48:1318-25. 2012
    ..We investigated the prognostic significance of intraductal carcinoma of the prostate (IDC-P) in biopsies and transurethral resections prior to external beam radiotherapy with or without androgen deprivation...
  3. doi request reprint International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume
    Theo H van der Kwast
    Department of Pathology, University Health Network and University of Toronto, Toronto, ON, Canada
    Mod Pathol 24:16-25. 2011
    ....
  4. doi request reprint Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies
    Theodorus H van der Kwast
    Department of Pathology, 11th Floor, University Health Network, 200 Elizabeth Street, Toronto M5G 2C4, Canada
    Am J Surg Pathol 34:169-77. 2010
    ....
  5. doi request reprint Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling
    Theodorus H van der Kwast
    Department of Pathology, University Health Network and University of Toronto, Canada
    Curr Opin Urol 19:516-21. 2009
    ..During the past few years, information on (epi)genetic and expression profiling of urothelial carcinomas has expanded, allowing a better appreciation of their correlation with clinicopathological features of bladder cancer...
  6. ncbi request reprint Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology
    Theodorus H van der Kwast
    Department of Pathology and Laboratory Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Ontario, Canada
    Anal Quant Cytol Histol 30:309-15. 2008
    ..To harmonize nomenclature, we now propose that the terms low and high grade papillary urothelial carcinoma be replaced by low and high grade papillary intraurothelial neoplasiafor all noninvasive urothelial cancers...
  7. ncbi request reprint Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911
    Theodorus H van der Kwast
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University Health Network, Toronto, Canada
    J Clin Oncol 25:4178-86. 2007
    ..Review pathology data of specimens from participants in this trial were analyzed to identify which factors predict increased benefit from adjuvant radiotherapy...
  8. pmc Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm?
    Th Van der Kwast
    Department of Pathology, University Health Network, Toronto, Ontario, Canada
    J Clin Pathol 60:585-6. 2007
  9. ncbi request reprint Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911)
    Theodorus H van der Kwast
    Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada, and Department of Urology, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium
    Virchows Arch 449:428-34. 2006
    ..05 and p>0.8). The observations suggest that review of pathological stage and surgical margin of radical prostatectomy strongly improves their prognostic impact in multi-institutional studies or trials...
  10. doi request reprint Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens
    Andrew J Evans
    Department of Pathology and Laboratory Medicine, University Health Network, Toronto, Ontario, Canada
    Am J Surg Pathol 32:1503-12. 2008
    ..Interobserver variability for EPE and SM interpretation was principally related to the lack of a clearly definable prostatic capsule and crush/thermal artifact along the edge of the gland, respectively...